MARK RICHARD J 4

What Happened Mark Richard J, a director of Tenet Healthcare Corp (THC), was granted 1,188 restricted stock units (RSUs) on 2026-05-27. The grant is reported as an "A" (award/grant) derivative acquisition at $0.00 — i.e., an equity award rather than a purchased security. No cash was paid for the grant; the filing does not state a market value or total dollar amount.

Key Details

• Transaction type: Award/Grant (Code A), derivative (restricted stock units).
• Grant date: 2026-05-27; Form 4 filed: 2026-05-28 (appears timely).
• Quantity: 1,188 RSUs; reported acquisition price: $0.00.
• Vesting/treatment: RSUs vest on the first anniversary of the grant date. The reporting person may elect to receive up to 37% of the RSUs in cash in lieu of shares (per filing footnote).
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• No 10b5-1 plan, tax-withholding, or sale activity noted in this transaction.

Context RSU grants are a common form of executive/director compensation and typically reflect compensation policy rather than a direct buy/sell signal. These RSUs are derivative awards that convert to common shares (or cash up to 37%) upon vesting one year from grant; they are not an open-market purchase or exercise of options.